Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides
- PMID: 16816551
- DOI: 10.1097/01.aids.0000232230.96134.80
Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides
Abstract
Objectives: Establishment of an in vitro model to evaluate rectal safety and the efficacy of microbicide candidates.
Design: An investigation and characterization of human colorectal explant culture for screening candidate microbicides to prevent rectal transmission of HIV-1 infection.
Methods: Human colorectal explants were cultured at the liquid-air interface on gelfoam rafts. Phenotypic characterization of HIV-1 target cells was performed by fluorescence-activated cell sorter analysis. HIV-1 infection was determined by the measurement of p24 antigen release, viral RNA, and proviral DNA accumulation.
Results: Colorectal explant CD4 T cells expressed higher CCR5 and CXCR4 levels compared with blood. Minor differences between the rectal and sigmoid colon were observed with a trend for slightly higher CCR5 and HLA-DR expression in cells from the sigmoid colon. Favourable culture conditions were established for colorectal tissue. Although tissue structure degenerated with time, CD4: CD8 cell ratios remained constant, and tissue supported productive HIV-1 infection. The ability of candidate microbicides to inhibit R5 HIV-1 infection was evaluated. Polyanion candidates, PRO2000 and dextrin sulphate, provided 99% protection at 1 microg/ml and 1 mg/ml, respectively, equivalent to 1/5000 and 1/40 of the vaginal formulations. The nucleotide reverse transcriptase inhibitor (NRTI) 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) provided protection at concentrations 1000-fold lower (10 microg/ml) than the proposed vaginal formulation (1%). Furthermore, non-NRTI UC-781 and TMC-120 provided greater than 99% inhibition at 3.3 or 0.33 microg/ml, respectively. No products demonstrated toxicity to rectal mucosa at inhibitory concentrations.
Conclusion: Colorectal explant culture was shown to be a useful tool for the preclinical evaluation of potential microbicides. The data suggest that rectally applied microbicides might provide protection from HIV-1 transmission.
Similar articles
-
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.PLoS Med. 2008 Aug 5;5(8):e157; discussion e157. doi: 10.1371/journal.pmed.0050157. PLoS Med. 2008. PMID: 18684007 Free PMC article.
-
Reverse transcriptase inhibitors as potential colorectal microbicides.Antimicrob Agents Chemother. 2009 May;53(5):1797-807. doi: 10.1128/AAC.01096-08. Epub 2009 Mar 2. Antimicrob Agents Chemother. 2009. PMID: 19258271 Free PMC article.
-
Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants.AIDS. 2011 Oct 23;25(16):1971-9. doi: 10.1097/QAD.0b013e32834b3629. AIDS. 2011. PMID: 21811139
-
Clinical development of microbicides for the prevention of HIV infection.Curr Pharm Des. 2004;10(3):315-36. doi: 10.2174/1381612043386374. Curr Pharm Des. 2004. PMID: 14754390 Review.
-
Rectal microbicide development.Curr Top Microbiol Immunol. 2014;383:117-36. doi: 10.1007/82_2013_325. Curr Top Microbiol Immunol. 2014. PMID: 23612991 Free PMC article. Review.
Cited by
-
HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease.J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):145-52. doi: 10.1097/QAI.0b013e31825ddbbf. J Acquir Immune Defic Syndr. 2012. PMID: 22659649 Free PMC article.
-
Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis.AIDS Res Hum Retroviruses. 2023 May;39(5):211-221. doi: 10.1089/AID.2021.0232. Epub 2023 Feb 15. AIDS Res Hum Retroviruses. 2023. PMID: 36416229 Free PMC article.
-
Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study.AIDS Res Hum Retroviruses. 2021 Jun;37(6):444-452. doi: 10.1089/AID.2020.0188. Epub 2021 Jan 25. AIDS Res Hum Retroviruses. 2021. PMID: 33371779 Free PMC article. Clinical Trial.
-
The Use of Droplet Digital PCR to Quantify HIV-1 Replication in the Colorectal Explant Model.AIDS Res Hum Retroviruses. 2019 Mar;35(3):326-334. doi: 10.1089/AID.2018.0227. Epub 2019 Feb 7. AIDS Res Hum Retroviruses. 2019. PMID: 30618283 Free PMC article. Clinical Trial.
-
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.J Virol. 2009 Jun;83(11):5592-605. doi: 10.1128/JVI.02051-08. Epub 2009 Mar 18. J Virol. 2009. PMID: 19297481 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials